Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W. Freyer, Selina M. Luger, Shannon R. McCurdy et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 10
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W. Freyer, Alison W. Loren, Alison Carulli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 10
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of StayCraig W. Freyer, David Porter, Shannon Gier et al.|Transplantation and Cellular Therapy|2021Cited by 3
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid MalignanciesMatthew P. Connor, Noelle V. Frey, Alison W. Loren et al.|Transplantation and Cellular Therapy|2022Cited by 3
Letermovir Vs High Dose Valacyclovir for Cytomegalovirus Prophylaxis Following Haploidentical Allogeneic Hematopoietic TransplantationCraig W. Freyer, Alison W. Loren, Alison Carulli et al.|Transplantation and Cellular Therapy|2021Cited by 0